257 related articles for article (PubMed ID: 24706428)
21. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
Kirbas A; Kirbas S; Cure MC; Tufekci A
J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052
[TBL] [Abstract][Full Text] [Related]
22. [Relationship between serum visfatin level and children and adolescent obesity and non-alcoholic fatty liver disease].
Wen H; Wang HJ; Dong B; Ma J
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):269-72. PubMed ID: 22613376
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
Liang S; Cheng X; Hu Y; Song R; Li G
Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
[TBL] [Abstract][Full Text] [Related]
24. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
[TBL] [Abstract][Full Text] [Related]
25. Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia.
Liang B; Li YH; Kong H
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2517-22. PubMed ID: 24089233
[TBL] [Abstract][Full Text] [Related]
26. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
27. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.
Köroğlu E; Canbakan B; Atay K; Hatemi İ; Tuncer M; Dobrucalı A; Sonsuz A; Gültepe I; Şentürk H
Turk J Gastroenterol; 2016 Jul; 27(4):361-6. PubMed ID: 27458852
[TBL] [Abstract][Full Text] [Related]
28. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease.
Pirgon O; Bilgin H; Tolu I; Odabas D
Clin Endocrinol (Oxf); 2011 Aug; 75(2):189-95. PubMed ID: 21521307
[TBL] [Abstract][Full Text] [Related]
29. P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease.
Ustyol A; Aycan Ustyol E; Gurdol F; Kokali F; Bekpınar S
Scand J Clin Lab Invest; 2017 May; 77(3):205-209. PubMed ID: 28318371
[TBL] [Abstract][Full Text] [Related]
30. Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease.
Pampanini V; Inzaghi E; Germani D; Alterio A; Puglianiello A; Alisi A; Nobili V; Cianfarani S
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):71-76. PubMed ID: 29122442
[TBL] [Abstract][Full Text] [Related]
31. Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.
Krzystek-Korpacka M; Patryn E; Hotowy K; Czapińska E; Majda J; Kustrzeba-Wójcicka I; Noczyńska A; Gamian A
Adv Clin Exp Med; 2013; 22(2):229-36. PubMed ID: 23709379
[TBL] [Abstract][Full Text] [Related]
32. Thyroid hormone levels in obese children and adolescents with non-alcoholic fatty liver disease.
Torun E; Özgen IT; Gökçe S; Aydın S; Cesur Y
J Clin Res Pediatr Endocrinol; 2014; 6(1):34-9. PubMed ID: 24637308
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents.
Assunção SNF; Sorte NCAB; Alves CAD; Mendes PSA; Alves CRB; Silva LR
Nutr Hosp; 2018 Jan; 35(1):78-83. PubMed ID: 29565153
[TBL] [Abstract][Full Text] [Related]
34. Serum oxidative stress parameters and paraoxonase-1 in children and adolescents exposed to passive smoking.
Kahraman FU; Torun E; Osmanoğlu NK; Oruçlu S; Özer ÖF
Pediatr Int; 2017 Jan; 59(1):68-73. PubMed ID: 27337344
[TBL] [Abstract][Full Text] [Related]
35. Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity.
Kim JY; Cho J; Yang HR
J Korean Med Sci; 2018 Apr; 33(16):e122. PubMed ID: 29651819
[TBL] [Abstract][Full Text] [Related]
36. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children.
Flisiak-Jackiewicz M; Bobrus-Chociej A; Tarasów E; Wojtkowska M; Białokoz-Kalinowska I; Lebensztejn DM
Can J Gastroenterol Hepatol; 2018; 2018():3870454. PubMed ID: 29854715
[TBL] [Abstract][Full Text] [Related]
37. Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease.
Angın Y; Arslan N; Kuralay F
Turk J Pediatr; 2014; 56(3):259-66. PubMed ID: 25341597
[TBL] [Abstract][Full Text] [Related]
38. Serum paraoxonase activity and oxidative status in subjects with alopecia areata.
Bilgili SG; Ozkol H; Karadag AS; Ozkol HU; Seker A; Calka O; Aslan M
Cutan Ocul Toxicol; 2013 Oct; 32(4):290-3. PubMed ID: 23590718
[TBL] [Abstract][Full Text] [Related]
39. Relationship between Neck Circumference and Non-Alcoholic Fatty Liver Disease in Childhood Obesity.
Hatipoğlu N; Doğan S; Mazıcıoğlu MM; Kurtoğlu S
J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):32-9. PubMed ID: 26758497
[TBL] [Abstract][Full Text] [Related]
40. [Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents].
Clemente AP; Netto BD; de Carvalho-Ferreira JP; da Silveira Campos RM; de Piano Ganen A; Tock L; de Mello MT; Dâmaso AR
Rev Paul Pediatr; 2016; 34(1):47-55. PubMed ID: 26830602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]